Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biostage Inc (NASDAQ:BSTG)

1.04
Delayed Data
As of Jun 24
 -0.06 / -5.45%
Today’s Change
0.53
Today|||52-Week Range
3.47
-52.29%
Year-to-Date
No recent news for Biostage Inc.

Today’s Trading

Previous close1.10
Today’s open1.02
Day’s range1.00 - 1.09
Volume94,466
Average volume (3 months)199,704
Market cap$17.8M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+25.53%
Earnings growth (this year)+22.86%
Earnings growth (next 5 years)--
Revenue growth (last year)+26.88%
P/E ratioNM
Price/Sales206.07
Price/Book1.77

Competitors

 Today’s
change
Today’s
% change
OCLSOculus Innovative Sc...+0.03+3.05%
CBYLCarbylan Therapeutic...-0.08-10.36%
MRICMRI Interventions In...-0.00-2.39%
NEPHNephros Inc0.000.00%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$118.0K
Annual profit (last year)-$11.7M
Net profit margin-9,918.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
James J. McGorry
Director-Quality &
Operations
Ginger A. Abraham-Freel
Corporate headquarters
Holliston, Massachusetts

Forecasts

Partner Offers

Search for Jobs